| Phase 3 |
| NCT05974774 |
Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors |
Prostate Cancer |
Recruiting |
| NCT04031677 |
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma |
Retroperitoneal Sarcoma |
Recruiting |
| NCT05815927 |
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer |
Oligometastatic Squamous Cell Carcinoma of the Head and Neck |
Recruiting |
| NCT05904119 |
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a… |
First Progression of Glioblastoma |
Recruiting |
| NCT06246149 |
Adjuvant Tebentafusp in High Risk Ocular Melanoma |
Uveal Melanoma |
Recruiting |
| NCT05512364 |
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) |
ER-positive Breast Cancer |
Recruiting |
| NCT06809322 |
Vorasidenib Maintenance for IDH Mutant Astrocytoma |
IDH-mutant Grade 2 or 3 Astrocytoma |
Recruiting |
| NCT00626990 |
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH) |
Brain and Central Nervous System Tumors |
Active, Not Recruiting |
| NCT06407401 |
Improvement of Quality of Life Through Supportive Treatments for Hormone Therapy… |
ER+ Breast Cancer |
Not Yet Recruiting |
| NCT00002462 |
RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's… |
Lymphoma |
Active, Not Recruiting |
| NCT00005584 |
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With… |
Lymphoma |
Active, Not Recruiting |
| NCT00379041 |
Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With… |
Lymphoma |
Active, Not Recruiting |
| NCT02194842 |
Phase III Radium 223 mCRPC-PEACE III |
Prostate Cancer |
Active, Not Recruiting |
| NCT02799706 |
Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH… |
Prostate Cancer |
Active, Not Recruiting |
| Phase 2/3 |
| NCT07425808 |
FLT3-ITD Targeted Therapy in Fit AML Patients |
AML (Acute Myeloid Leukemia) |
Not Yet Recruiting |
| Phase 2 |
| NCT04128072 |
Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB)… |
Stage IB-IIB Cutaneous T-Cell Lymphoma |
Recruiting |
| NCT06783348 |
Radiopharmaceutical Treatment of Advanced Kidney Cancer |
Metastatic Clear Cell Renal Cell Carcinoma |
Recruiting |
| NCT06326190 |
177Lu-DOTATATE for Recurrent Meningioma |
Recurrent Meningioma |
Recruiting |
| NCT06310369 |
Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder… |
Bladder Cancer |
Not Yet Recruiting |
| NCT04127110 |
Activity of Lorlatinib Based on ALK Resistance Mutations Detected on Blood in ALK… |
Non Small Cell Lung Cancer |
Active, Not Recruiting |
| NCT03235245 |
Immunotherapy With Ipilimumab and Nivolumab Preceded or Not by a Targeted Therapy With… |
Unresectable Stage III Melanoma |
Active, Not Recruiting |
| NCT03517137 |
Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single… |
Advanced Hodgkin Lymphoma |
Active, Not Recruiting |
| NCT02972060 |
ODM-201 vs Androgen Deprivation Therapy in Hormone naïve Prostate Cancer |
Prostate Cancer |
Active, Not Recruiting |
| NCT03609047 |
Adjuvant Palbociclib in Elderly Patients With Breast Cancer |
Breast Cancer Stage II |
Active, Not Recruiting |
| NCT03134118 |
Nivolumab in Patients With Type B3 Thymoma and Thymic Carcinoma (NIVOTHYM) |
Thymoma Type B3 |
Active, Not Recruiting |